[1]
“A Pilot Study, to Evaluate the Safety and Efficacy of Topically Applied Onabotulinum Toxin A Delivered through a Novel Iontophoresis Device in Subjects with Axillary Hyperhidrosis”, J of Skin, vol. 7, no. 2, p. s199, Mar. 2023, doi: 10.25251/skin.7.supp.199.